María Martínez
Finanzdirektor/CFO bei Progenika Biopharma SA
Aktive Positionen von María Martínez
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Progenika Biopharma SA
Progenika Biopharma SA Medical SpecialtiesHealth Technology Progenika Biopharma SA engages in the design and development of molecular biology testing solutions. The firm offers ID Core Control, ID RHD, ID Core, SeqPro Lipo IS, and A1AT genotyping test. The company was founded in 2000 and is headquartered in Derio, Spain. | Finanzdirektor/CFO | - | - |
Karriereverlauf von María Martínez
Ehemalige bekannte Positionen von María Martínez
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BRAINco Biopharma SL
BRAINco Biopharma SL Medical SpecialtiesHealth Technology BRAINco Biopharma SL develops and produces diagnosis and treatment for neurological and psychiatric diseases. It develops drugs directed against therapeutic targets and diagnostic biochips, prognosis, and prediction of individual response to drug treatment. The company was founded by Laureano Simon Buela in 2008 and is headquartered in Bilbao, Spain. | Finanzdirektor/CFO | 24.05.2011 | - |
Ausbildung von María Martínez
University of Deusto | Undergraduate Degree |
Statistik
International
Spanien | 4 |
Operativ
Director of Finance/CFO | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Progenika Biopharma SA
Progenika Biopharma SA Medical SpecialtiesHealth Technology Progenika Biopharma SA engages in the design and development of molecular biology testing solutions. The firm offers ID Core Control, ID RHD, ID Core, SeqPro Lipo IS, and A1AT genotyping test. The company was founded in 2000 and is headquartered in Derio, Spain. | Health Technology |
BRAINco Biopharma SL
BRAINco Biopharma SL Medical SpecialtiesHealth Technology BRAINco Biopharma SL develops and produces diagnosis and treatment for neurological and psychiatric diseases. It develops drugs directed against therapeutic targets and diagnostic biochips, prognosis, and prediction of individual response to drug treatment. The company was founded by Laureano Simon Buela in 2008 and is headquartered in Bilbao, Spain. | Health Technology |
- Börse
- Insiders
- María Martínez
- Erfahrung